What's new

Opinion/decision on a Paediatric investigation plan (PIP): Lokelma, sodium zirconium cyclosilicate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Metabolism and nutrition disorders, PIP number: P/0077/2024

Opinion/decision on a Paediatric investigation plan (PIP): Lokelma, sodium zirconium cyclosilicate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Metabolism and nutrition disorders, PIP number: P/0077/2024

Apr 14, 2025 - 14:30
 0
Opinion/decision on a Paediatric investigation plan (PIP): Lokelma, sodium zirconium cyclosilicate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Metabolism and nutrition disorders, PIP number: P/0077/2024
Opinion/decision on a Paediatric investigation plan (PIP): Lokelma, sodium zirconium cyclosilicate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Metabolism and nutrition disorders, PIP number: P/0077/2024
Read More

Tags:

Previous Article

STAT+: How a downturn in biotech may be felt in Kendall Square, an industry hub

Next Article

The Democratization of Investing: Expanding Prosperity in More Places, for More ...

Related Posts

Human medicines European public assessment report (EPAR): Jubereq, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR...

Mar 28, 2025  0

Contacts at the European Medicines Agency

Contacts at the European Medicines Agency

Mar 14, 2025  0

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0